NabGen Inc.
NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors.
Company Details
Company type
Year founded
2019
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)